卓越成果
Disease Area/ Indication |
Name of PI |
Name of Trial |
phase I-III |
Name of sponsor |
Remarks |
Mucopolysaccharidosis |
|
CNS Unmet Medical Need in Mucopolysaccharidosis: A Phase 2 Safety and Pharmacokinetics Study of Ataluren |
II |
PTC |
|
Cancer - Solid Tumor |
|
A phase II, multicenter study of EZH2 inhibitor in Adult subjects with INI1-negative tumors or relapsed/refractory synovial scarcoma |
II |
Epizyme |
|
Opioid Dependence |
|
An Open-Label Multicenter Study Assessing the Long-Term Safety of a Once-Weekly and Once-Monthly, Long-Acting Subcutaneous Injection Depot of Buprenorphine in Adult Outpatients with Opioid Use Disorder |
II |
Braeburn |
|
Familial Amyloidotic Polyneuropahty |
|
A Phase 3 Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Patisiran in Transthyretin (TTR)-Mediated Polyneuropathy |
III |
Alnylam |
|
Homozygous Familial Hypercholesterolemia |
|
A Randomized, Double-Blind, Placebo-controlled, Multi-center, Cross-over Study of Rosuvastatin in Children and Adolescents with Homozygous Familial Hypercholesterolemia |
III |
AstraZeneca |
|
Urinary Tract Infection |
|
A Multi-Center, Randomized, Double-Blind, Double-Dummy, Study to Evaluate the Efficacy, Safety, and Tolerability of Carbavance Compared to Piperacillin/Tazobactam in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis |
III |
Rempex |
|
Heterozygous Familial Hypercholesterolemia |
|
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients with Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol |
III |
Genzyme |
|
專長服務項目
- MDs – Regulatory – Operational
- Therapeutic – Global – Phase I thru IV
- Disciplined Processes – Quality Control - Site Relationships – Technology
- Clinical Pharmacology Unit – Central Lab – Bioanalytical Lab – Imaging Lab – ECG Lab